[177Lu]-PSMA-I&T solution for injection, 7,400 MBq

Summary

The Institute of Nuclear and Molecular Medicine is procuring lutetium-177 PSMA-I&T solution for injection, with an activity of 7,400 MBq on the calibration date. The contract is a 24-month framework agreement for an estimated 200 packages/vials, with delivery to the Institute’s premises in Košice; the estimated value is EUR 1,500,000 excluding VAT. The procurement is not divided into lots.